STOCK TITAN

Preaxia Health Care Pmt Sys In Financials

PAXH
Source SEC Filings (10-K/10-Q) Updated Feb 28, 2026 Currency USD FYE May

This page shows Preaxia Health Care Pmt Sys In (PAXH) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI PAXH FY2025

Liabilities dwarf the entire asset base, leaving the company with almost no operating cushion and little balance-sheet support.

From FY2022 to FY2024, cash and total assets fell from $259 to $14 while total liabilities increased from $2.1M to $2.4M. Because cash matched essentially all reported assets in each valid year, the company has not built an asset base that could offset or refinance those obligations.

The balance sheet is almost entirely current liabilities, and the current ratio sat near zero in every valid year, so this looks like a short-term liquidity strain rather than a business funding itself with long-lived operating assets. The last valid revenue figure was only $368 in FY2022, showing how disconnected the liability load is from recent operating scale.

Some figures from recent filings were inconsistent and were omitted from this summary.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 0 / 100
Financial Profile 0/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Preaxia Health Care Pmt Sys In's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Liquidity
0

Preaxia Health Care Pmt Sys In's current ratio of 0.00 is below the typical benchmark, resulting in a score of 0/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Earnings Quality Low Quality
0.51x

For every $1 of reported earnings, Preaxia Health Care Pmt Sys In generates $0.51 in operating cash flow (-$42K OCF vs -$82K net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$0

Preaxia Health Care Pmt Sys In generated $0 in revenue in fiscal year 2025.

EBITDA
N/A
Net Income
-$82K

Preaxia Health Care Pmt Sys In reported -$82K in net income in fiscal year 2025.

EPS (Diluted)
$-0.00
YoY+92.0%

Preaxia Health Care Pmt Sys In earned $-0.00 per diluted share (EPS) in fiscal year 2025. This represents an increase of 92.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow
N/A
Cash & Debt
$0
YoY-100.0%

Preaxia Health Care Pmt Sys In held $0 in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
20M
YoY+0.0%
5Y CAGR+0.0%

Preaxia Health Care Pmt Sys In had 20M shares outstanding in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Margins & Returns

Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
Return on Equity
N/A

Capital Allocation

R&D Spending
$0

Preaxia Health Care Pmt Sys In invested $0 in research and development in fiscal year 2025.

Share Buybacks
N/A
Capital Expenditures
N/A

PAXH Income Statement

Metric Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24
Revenue $0 $0 $0 N/A $0 $0 $0 N/A
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses $0 $0-100.0% $391K N/A $0 $0 $0 N/A
SG&A Expenses $5K+16.1% $5K-43.2% $8K N/A N/A N/A N/A N/A
Operating Income -$95K+15.5% -$112K+87.2% -$875K N/A N/A N/A N/A N/A
Interest Expense $0 $0+100.0% -$69 N/A N/A $0 $0 N/A
Income Tax $0 $0 $0 N/A $0 $0 $0 N/A
Net Income -$94K+15.6% -$112K+87.2% -$875K N/A N/A N/A N/A N/A
EPS (Diluted) $0.00 $0.00+100.0% $-0.04 N/A $0.00 $0.00 $0.00 N/A

PAXH Balance Sheet

Metric Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24
Total Assets $443K+208.3% $144K-87.5% $1.2M $0-100.0% $3-98.2% $165+16400.0% $1-92.9% $14
Current Assets $57K+314.1% $14K-97.2% $490K $0-100.0% $3-98.2% $165+16400.0% $1-92.9% $14
Cash & Equivalents $57K+314.1% $14K-89.4% $130K $0-100.0% $3-98.2% $165+16400.0% $1-92.9% $14
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $807K+5.0% $769K-56.3% $1.8M-24.9% $2.3M-3.4% $2.4M+0.4% $2.4M+0.6% $2.4M+0.2% $2.4M
Current Liabilities $807K+5.0% $769K+6.3% $723K-69.1% $2.3M-3.6% $2.4M+0.6% $2.4M+0.6% $2.4M+0.2% $2.4M
Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A
Total Equity -$364K+41.8% -$625K-2.7% -$608K+74.0% -$2.3M+3.4% -$2.4M-0.4% -$2.4M-0.6% -$2.4M-0.2% -$2.4M
Retained Earnings -$6.2M-1.6% -$6.1M+0.3% -$6.1M-16.8% -$5.2M-1.0% -$5.2M-0.3% -$5.1M-0.3% -$5.1M-0.1% -$5.1M

PAXH Cash Flow Statement

Metric Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24
Operating Cash Flow $5K+113.1% -$39K+48.0% -$75K-317.7% -$18K N/A N/A N/A N/A
Capital Expenditures $137K N/A N/A N/A $0 N/A N/A N/A
Free Cash Flow -$132K N/A N/A N/A N/A N/A N/A N/A
Investing Cash Flow -$137K-94.2% -$71K $0 $0 $0 $0 $0 $0
Financing Cash Flow $176K+5880.6% -$3K-101.5% $205K+1206.7% $16K $0 N/A N/A N/A
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

PAXH Financial Ratios

Metric Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin N/A N/A N/A N/A N/A N/A N/A N/A
Net Margin N/A N/A N/A N/A N/A N/A N/A N/A
Return on Equity N/A N/A -143.8% N/A N/A N/A N/A N/A
Return on Assets -21.3%+56.5pp -77.8%-1.8pp -76.1% N/A N/A N/A N/A N/A
Current Ratio 0.07+0.1 0.02-0.7 0.68+0.7 0.000.0 0.000.0 0.000.0 0.000.0 0.00
Debt-to-Equity -2.22-1.0 -1.23+1.7 -2.89-1.9 -1.000.0 -1.000.0 -1.000.0 -1.000.0 -1.00
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Note: Shareholder equity is negative (-$2.3M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.00), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Frequently Asked Questions

Preaxia Health Care Pmt Sys In (PAXH) reported $0 in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

No, Preaxia Health Care Pmt Sys In (PAXH) reported a net income of -$82K in fiscal year 2025.

Preaxia Health Care Pmt Sys In (PAXH) reported diluted earnings per share of $-0.00 for fiscal year 2025. This represents a 92.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Preaxia Health Care Pmt Sys In (PAXH) generated -$42K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Preaxia Health Care Pmt Sys In (PAXH) had $0 in total assets as of fiscal year 2025, including both current and long-term assets.

Preaxia Health Care Pmt Sys In (PAXH) had 20M shares outstanding as of fiscal year 2025.

Preaxia Health Care Pmt Sys In (PAXH) had a current ratio of 0.00 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

Preaxia Health Care Pmt Sys In (PAXH) had a debt-to-equity ratio of -1.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Based on fiscal year 2025 data, Preaxia Health Care Pmt Sys In (PAXH) had $0 in cash against an annual operating cash burn of $42K. This gives an estimated cash runway of approximately 0 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Preaxia Health Care Pmt Sys In (PAXH) has negative shareholder equity of -$2.3M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Preaxia Health Care Pmt Sys In (PAXH) has an earnings quality ratio of 0.51x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Preaxia Health Care Pmt Sys In (PAXH) scores 0 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top